APA (7th ed.) Citation

CM, K., CA, R., LE, N., E, P., J, K., JD, S., . . . EJ, A. (2024). A Phase 1, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of HEV-239 (Hecolin) Vaccine in Healthy US Adults. The Journal of infectious diseases, 230(5), 1093. https://doi.org/10.1093/infdis/jiae148

Chicago Style (17th ed.) Citation

CM, Kao, et al. "A Phase 1, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of HEV-239 (Hecolin) Vaccine in Healthy US Adults." The Journal of Infectious Diseases 230, no. 5 (2024): 1093. https://doi.org/10.1093/infdis/jiae148.

MLA (9th ed.) Citation

CM, Kao, et al. "A Phase 1, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of HEV-239 (Hecolin) Vaccine in Healthy US Adults." The Journal of Infectious Diseases, vol. 230, no. 5, 2024, p. 1093, https://doi.org/10.1093/infdis/jiae148.